KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and[...]
City of Seattle Expands Vaccination Efforts Creating Multiple Fixed[...]
AdvaMed - Advanced Medical[...]
AdvaMed Applauds NJ Appellate Division for Reversing Trial Court Order[...]
02/08/2021 | Press release | Distributed by Public on 02/08/2021 15:11
Please select the service you want to use:
Smartlinks | AquaBounty Technologies Inc. | News | Health | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | IPO | Public Share Offering | Investment Services | Fishing Industry | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2021 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact